Hepatiq, Inc.

Hepatiq, Inc. announced today that Ronald A. Blum has joined the management team as a marketing consultant.

HEPATIQ LLC announced that they received clearance from the U.S. Food and Drug Administration to add two additional indices of liver disease severity to their product.

HEPATIQ® LLC announced that they have been granted U.S. Patent 9,155,513 titled “Systems and Methods for Determining Hepatic Function from Liver Scans”.